Yearly Archives: 2015

Survey: Majority of Women Do Not Discuss Breast Cancer Risks or Mammography Screening Limitations with Healthcare Providers

Cambridge, Mass. – May 5, 2015 – sphingotec, LLC, predictive diagnostic tests for cancer, cardiovascular diseases and kidney function, today announced the results of a survey gauging women’s understanding of breast cancer risk factors and their perceptions of common breast cancer screening methods. The survey was conducted in conjunction with a national, independent health information…
Read more

Researchers Link Low Levels of Pro-Enkephalin to Future Breast Cancer in Healthy Women

sphingotec announces the publication of trial results showing the strong association between low pro-enkephalin (pro-ENK) levels in plasma and incident breast cancer Cambridge, Mass. – July 15, 2015 – sphingotec LLC announced today that the results of two studies examining the association between proenkephalin (pro-ENK) and incident breast cancer were published online in the Journal…
Read more

Majority of Women Do Not Discuss Breast Cancer Risks with Healthcare Providers

sphingotec, LLC, a developer of predictive diagnostic tests for cancer, cardiovascular diseases and kidney function, today announced the results of a survey gauging women’s understanding of breast cancer risk factors and their perceptions of common breast cancer screening methods. The survey was conducted in conjunction with a national, independent health information resource for women, and…
Read more

sphingotec at the St. Gallen International Breast Cancer Conference

Biotech company to present how biomarkers improve breast cancer risk prediction in women under hormone replacement therapy. Cambridge, Mass. – Feb. 4, 2015 – sphingotec LLC announced today that the findings from its research seeking to improve breast cancer risk stratification for guiding hormone replacement therapy has been selected for presentation at the 14th annual…
Read more

Top